REGENEREX PHARMA, INC. Depreciation and Amortization Expense
REGENEREX PHARMA, INC. reported Depreciation and Amortization Expense of $833 for the 29-month period ending 2012-11-30, per its 10-K/A filed 2013-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2013-02-28
- REGENEREX PHARMA, INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2010-11-30 was $0.00.
- REGENEREX PHARMA, INC. depreciation, depletion and amortization, nonproduction for fiscal 2012 was $833.00.
- REGENEREX PHARMA, INC. depreciation, depletion and amortization, nonproduction for fiscal 2010 was $476.00, a 84.47% decline from fiscal 2009.
- REGENEREX PHARMA, INC. depreciation, depletion and amortization, nonproduction for fiscal 2009 was $3.07K.
| Period end | Depreciation, Depletion and Amortization, Nonproduction 3 month | Depreciation, Depletion and Amortization, Nonproduction 9 month | Depreciation, Depletion and Amortization, Nonproduction 12 month | Depreciation, Depletion and Amortization, Nonproduction 29 month |
|---|---|---|---|---|
| 2012-11-30 | $833.00 10-K/A · filed 2013-02-28 | $833.00 10-K/A · filed 2013-02-28 | ||
| 2010-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $476.00 10-K · filed 2012-02-28 | ||
| 2010-08-31 | $476.00 10-Q · filed 2011-10-13 | |||
| 2009-11-30 | $3.07K 10-K · filed 2012-02-28 |